Suppr超能文献

组织 Ki67 增殖指数表达与血液透析动静脉瘘的病理变化:初步单中心研究结果。

Tissue Ki67 proliferative index expression and pathological changes in hemodialysis arteriovenous fistulae: Preliminary single-center results.

机构信息

Department of Specialty, Diagnostic and Experimental Medicine, S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.

出版信息

J Vasc Access. 2023 May;24(3):391-396. doi: 10.1177/11297298211015495. Epub 2021 Jul 24.

Abstract

BACKGROUND

Arteriovenous fistula (AVF) for hemodialysis integrates outward remodeling with vessel wall thickening in response to drastic hemodynamic changes. Aim of this study is to determine the role of Ki67, a well-established proliferative marker, related to AVF, and its relationship with time-dependent histological morphologic changes.

MATERIALS AND METHODS

All patients were enrolled in 1 year and stratified in two groups: (A) pre-dialysis patients submitted to first AVF and (B) patients submitted to revision of AVF. Morphological changes: neo-angiogenesis (NAG), myointimal thickening (MIT), inflammatory infiltrate (IT), and aneurysmatic fistula degeneration (AD). The time of AVF creation was recorded. A biopsy of native vein in Group A and of arterialized vein in Group B was submitted to histological and immunohistochemical (IHC) analysis. IHC for Ki67 was automatically performed in all specimens. Ki67 immunoreactivity was assessed as the mean number of positive cells on several high-power fields, counted in the hot spots.

RESULTS

A total of 138 patients were enrolled, 69 (50.0%) Group A and 69 (50.0%) Group B. No NAG or MIT were found in Group A. Seven (10.1%) Group A veins showed a mild MIT. Analyzing the Group B, a moderate-to-severe MIT was present in 35 (50.7%), IT in 19 (27.5%), NAG in 37 (53.6%); AD was present in 10 (14.5%). All AVF of Group B with the exception of one (1.4%) showed a positivity for Ki67, with a mean of 12.31 ± 13.79 positive cells/hot spot (range 0-65). Ki67-immunoreactive cells had a subendothelial localization in 23 (33.3%) cases, a myointimal localization in SMC in 35 (50.7%) cases. The number of positive cells was significantly correlated with subendothelial localization of Ki67 ( = 0.001) and with NA ( = 0.001).

CONCLUSIONS

Native veins do not contain cycling cells. In contrast, vascular cell proliferation starts immediately after AVF creation and persists independently of the time the fistula is set up. The amount of proliferating cells is significantly associated with MIT and subendothelial localization of Ki67-immunoreactive cells, thus suggesting a role of Ki-67 index in predicting AVF failure.

摘要

背景

动静脉瘘(AVF)用于血液透析,通过血管壁增厚来整合外向重塑,以应对剧烈的血液动力学变化。本研究旨在确定增殖标志物 Ki67 在 AVF 中的作用及其与时间相关的组织形态学变化的关系。

材料和方法

所有患者均在 1 年内入组,并分为两组:(A)透析前患者接受首次 AVF 治疗,(B)AVF 修复患者。形态学变化:新生血管形成(NAG)、内膜增厚(MIT)、炎症浸润(IT)和动脉瘤性瘘管退化(AD)。记录 AVF 的创建时间。A 组的静脉和 B 组的动脉化静脉进行活检,并进行组织学和免疫组织化学(IHC)分析。所有标本均自动进行 Ki67 的免疫组化。Ki67 免疫反应性作为多个高倍视野中阳性细胞的平均值进行评估,在热点处计数。

结果

共纳入 138 例患者,其中 69 例(50.0%)为 A 组,69 例(50.0%)为 B 组。A 组未见 NAG 或 MIT。A 组中有 7 例(10.1%)静脉有轻度 MIT。分析 B 组,35 例(50.7%)有中重度 MIT,19 例(27.5%)有 IT,37 例(53.6%)有 NAG;10 例(14.5%)有 AD。B 组除 1 例(1.4%)外,所有 AVF 均 Ki67 阳性,平均每高倍视野有 12.31±13.79 个阳性细胞(范围 0-65)。Ki67 免疫反应性细胞在下皮下有 23 例(33.3%),在血管平滑肌中有 35 例(50.7%)。阳性细胞数量与 Ki67 的皮下定位( = 0.001)和 NA( = 0.001)显著相关。

结论

天然静脉不含有增殖细胞。相反,血管细胞增殖在动静脉瘘建立后立即开始,并持续存在,与瘘管建立时间无关。增殖细胞的数量与 MIT 和 Ki67 免疫反应性细胞的皮下定位显著相关,提示 Ki-67 指数在预测动静脉瘘失功中的作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验